BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37068086)

  • 1. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.
    Jeyapalina S; Wei G; Stoddard GJ; Sudduth JD; Lundquist M; Huntsman M; Marquez JL; Agarwal JP
    PLoS One; 2023; 18(4):e0284520. PubMed ID: 37068086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
    Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
    BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
    Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
    Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
    [No Abstract]   [Full Text] [Related]  

  • 4. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural network based prediction of the lung tissue involvement as an independent in-hospital mortality and mechanical ventilation risk factor in COVID-19.
    Parczewski M; Kufel J; Aksak-Wąs B; Piwnik J; Chober D; Puzio T; Lesiewska L; Białkowski S; Rafalska-Kosior M; Wydra J; Awgul K; Grobelna M; Majchrzak A; Dunikowski K; Jurczyk K; Podyma M; Serwin K; Musiałek J
    J Med Virol; 2023 May; 95(5):e28787. PubMed ID: 37219059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Significance of Procalcitonin Elevation in Patients over 75 Years Old Admitted for COVID-19 Pneumonia.
    Ticinesi A; Nouvenne A; Prati B; Guida L; Parise A; Cerundolo N; Bonaguri C; Aloe R; Guerra A; Meschi T
    Mediators Inflamm; 2021; 2021():5593806. PubMed ID: 34326704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
    Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
    Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death.
    Ramonfaur D; Aguirre-García GM; Diaz-Garza CA; Torre-Amione G; Sanchez-Nava VM; Lara-Medrano R; Ramírez-Elizondo MT; Esparza-Sandoval AC; Ortega-Hernández FJ; Martínez-Reséndez MF
    Infect Dis (Lond); 2022 Nov; 54(11):810-818. PubMed ID: 35854671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of critical care, mechanical ventilation, and mortality among hospitalized patients with COVID-19 in an electronic health record database.
    Chomistek AK; Liang C; Doherty MC; Clifford CR; Ogilvie RP; Gately RV; Song JN; Enger C; Lin ND; Wang FT; Seeger JD
    BMC Infect Dis; 2022 Apr; 22(1):413. PubMed ID: 35488229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early predictors for mechanical ventilation in COVID-19 patients.
    Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
    Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
    Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
    Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization, mechanical ventilation, and case-fatality outcomes in US veterans with COVID-19 disease between years 2020-2021.
    Luo J; Rosales M; Wei G; Stoddard GJ; Kwok AC; Jeyapalina S; Agarwal JP
    Ann Epidemiol; 2022 Jun; 70():37-44. PubMed ID: 35462045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
    Vazzana N; Dipaola F; Ognibene S
    Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.
    Cardemil CV; Dahl R; Prill MM; Cates J; Brown S; Perea A; Marconi V; Bell L; Rodriguez-Barradas MC; Rivera-Dominguez G; Beenhouwer D; Poteshkina A; Holodniy M; Lucero-Obusan C; Balachandran N; Hall AJ; Kim L; Langley G
    JMIR Public Health Surveill; 2021 Jan; 7(1):e24502. PubMed ID: 33338028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
    López-Ayala P; Alcaraz-Serna A; Valls Carbó A; Cuadrado Cenzual MÁ; Torrejón Martínez MJ; López Picado A; Martínez Valero C; Miranda JD; Díaz Del Arco C; Cozar López G; Suárez-Cadenas MDM; Jerez Fernández P; Angós B; Rodríguez Adrada E; Cardassay E; Del Toro E; Chaparro D; Montalvo Moraleda MT; Espejo Paeres C; García Briñón MÁ; Hernández Martín-Romo V; Ortega L; Fernández Pérez C; Martínez-Novillo M; González Armengol JJ; González Del Castillo J; Mueller CE; Martín-Sánchez FJ;
    Emergencias; 2022 Apr; 34(2):119-127. PubMed ID: 35275462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.